Anti-KDM6B monoclonal antibody

Pre-made anti-KDM6B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KDM6B/KDM6B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T56057-Ab-1/ GM-Tg-hg-T56057-Ab-2Anti-Human KDM6B monoclonal antibodyHuman
GM-Tg-rg-T56057-Ab-1/ GM-Tg-rg-T56057-Ab-2Anti-Rat KDM6B monoclonal antibodyRat
GM-Tg-mg-T56057-Ab-1/ GM-Tg-mg-T56057-Ab-2Anti-Mouse KDM6B monoclonal antibodyMouse
GM-Tg-cynog-T56057-Ab-1/ GM-Tg-cynog-T56057-Ab-2Anti-Cynomolgus/ Rhesus macaque KDM6B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T56057-Ab-1/ GM-Tg-felg-T56057-Ab-2Anti-Feline KDM6B monoclonal antibodyFeline
GM-Tg-cang-T56057-Ab-1/ GM-Tg-cang-T56057-Ab-2Anti-Canine KDM6B monoclonal antibodyCanine
GM-Tg-bovg-T56057-Ab-1/ GM-Tg-bovg-T56057-Ab-2Anti-Bovine KDM6B monoclonal antibodyBovine
GM-Tg-equg-T56057-Ab-1/ GM-Tg-equg-T56057-Ab-2Anti-Equine KDM6B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T56057-Ab-1/ GM-Tg-hg-T56057-Ab-2; GM-Tg-rg-T56057-Ab-1/ GM-Tg-rg-T56057-Ab-2;
GM-Tg-mg-T56057-Ab-1/ GM-Tg-mg-T56057-Ab-2; GM-Tg-cynog-T56057-Ab-1/ GM-Tg-cynog-T56057-Ab-2;
GM-Tg-felg-T56057-Ab-1/ GM-Tg-felg-T56057-Ab-2; GM-Tg-cang-T56057-Ab-1/ GM-Tg-cang-T56057-Ab-2;
GM-Tg-bovg-T56057-Ab-1/ GM-Tg-bovg-T56057-Ab-2; GM-Tg-equg-T56057-Ab-1/ GM-Tg-equg-T56057-Ab-2
Products NameAnti-KDM6B monoclonal antibody
Formatmab
Target NameKDM6B
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KDM6B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T56057-Ag-1Recombinant multi-species KDM6B/ JMJD3 protein


    Target information

    Target IDGM-T56057
    Target NameKDM6B
    Gene ID23135,216850,363630,716348,489481,101100010,100140276,100073033
    Gene Symbol and Synonyms1700064E03Rik,JMJD3,KDM6B,NEDCFSA
    Uniprot AccessionO15054
    Uniprot Entry NameKDM6B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000132510
    Target ClassificationN/A

    The target: KDM6B, gene name: KDM6B, also named as JMJD3. The protein encoded by this gene is a lysine-specific demethylase that specifically demethylates di- or tri-methylated lysine 27 of histone H3 (H3K27me2 or H3K27me3). H3K27 trimethylation is a repressive epigenetic mark controlling chromatin organization and gene silencing. This protein can also demethylate non-histone proteins such as retinoblastoma protein. Through its demethylation actvity this gene influences cellular differentiation and development, tumorigenesis, inflammatory diseases, and neurodegenerative diseases. This protein has two classical nuclear localization signals at its N-terminus. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.